Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 812 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Contraception and cancer – a look behind the headlines March 21, 2023 In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in... March 10, 2026 Bariatric Surgery May Reduce the Risk of Some Common Cancers December 2, 2022 Screening for Many Cancers with One Test: Uncertainty Abounds April 21, 2022 Load more HOT NEWS Findings support de-escalated radiotherapy after surgery in HPV-associated oropharyngeal squamous cell... Gene Tied to Alzheimer’s May Be Associated with Cancer-Related Cognitive Problems Analysis of the Gut Microbiome Provides Clues to Survival Following Nivolumab... 40 K9 Officers Line Up Outside Terminally Ill Girl’s House For...
